Integer Holdings Corporation ITGR

Integer Holdings Corporation es una empresa de fabricación de dispositivos médicos externalizados (MDO). La empresa atiende a los mercados de gestión del ritmo cardíaco, neuromodulación, ortopedia, vascular, cirugía avanzada y dispositivos médicos portátiles. Proporciona tecnologías médicas a nivel mundial. Además, la empresa desarrolla baterías para aplicaciones en los mercados de energía, militar y medio ambiente. Sus marcas incluyen Greatbatch Medical, Lake Region Medical y Electrochem. La empresa tiene dos segmentos: Médico y No Médico. El segmento Médico incluye las líneas de productos cardiovasculares y vasculares; gestión del ritmo cardíaco y neuromodulación y cirugía avanzada; ortopedia y dispositivos médicos portátiles. El segmento No Médico comprende la línea de productos Electrochem. Electrochem proporciona sistemas personalizados de energía y gestión de energía de baterías. Electrochem diseña y fabrica soluciones de baterías primarias personalizadas (no recargables), que se utilizan en los mercados de energía, militar y medio ambiente.

• GlobeNewswire Inc. 30 sept

  Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed transactions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholder interests.

  

• Zacks Investment Research 30 sept

  GMED vs. ITGR: Which Stock Is the Better Value Option?

  In a comparison of two medical instruments stocks, Globus Medical (GMED) emerges as the superior value option over Integer (ITGR). GMED holds a Zacks Rank of #1 (Strong Buy) with improving earnings outlook, while ITGR has a Zacks Rank of #3 (Hold). GMED also demonstrates better valuation metrics with a forward P/E of 15.18 versus ITGR's 20.74, and a PEG ratio of 1.22 compared to ITGR's 2.40, earning GMED a Value grade of B versus ITGR's C.

  

• Zacks Investment Research 14 sept

  GMED vs. ITGR: Which Stock Should Value Investors Buy Now?

  Globus Medical (GMED) and Integer (ITGR) are compared as potential value investments in the medical instruments sector. GMED emerges as the superior value option with a Zacks Rank #1 (Strong Buy) rating, lower forward P/E ratio of 14.88 versus ITGR's 20.68, and a Value grade of B compared to ITGR's C grade. GMED also shows stronger earnings estimate revisions and more favorable valuation metrics across multiple indicators.

  

• Zacks Investment Research 27 ago

  GMED or ITGR: Which Is the Better Value Stock Right Now?

  In a comparison of two medical instruments stocks, Globus Medical (GMED) emerges as the superior value option over Integer (ITGR). GMED holds a Zacks Rank #1 (Strong Buy) with a Value grade of B, featuring a lower forward P/E ratio of 16.86 and PEG ratio of 1.35. ITGR carries a Zacks Rank #3 (Hold) with a Value grade of C, posting a higher forward P/E of 20.55 and PEG ratio of 2.96. Based on valuation metrics and earnings outlook, GMED is positioned as the more attractive choice for value investors.

  

• GlobeNewswire Inc. 3 ago

  Halper Sadeh LLC is Investigating Whether SUPN, ITGR, BOW are Obtaining Fair Deals for their Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating three major corporate transactions for potential securities law violations and breaches of fiduciary duties. The investigations involve Supernus Pharmaceuticals' sale to Indivior, Integer Holdings' acquisition by KKR, and Bowhead Specialty Holdings' sale to American Family Mutual Insurance. The firm is seeking increased consideration and additional disclosures on behalf of shareholders.